High frequency of genomic instability in Ewing family of tumors

Cancer Genetics and Cytogenetics

Volumn 150, Issue 1, 2004, Pages 50-56

  Ohali, Anat ^a   Avigad, Smadar ^a   Cohen, Ian J ^a   Meller, Isaac ^a   Kollender, Yehuda ^a   Issakov, Josephine ^a   Goshen, Yacov ^a   Yaniv, Isaac ^a   Zaizov, Rina ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; EWING SARCOMA; FEMALE; GENE FREQUENCY; GENE LOCUS; GENOMICS; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; GENE FREQUENCY; GENOMIC INSTABILITY; HUMANS; INFANT; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; PROGNOSIS; SARCOMA, EWING'S; SURVIVAL RATE;

EID: 1642354324     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.08.014     Document Type: Article

References (59)

1. Ginsberg J.P., Woo S.Y., Johnson M.E., Hick M.J., Horowitz M.E. Ewing sarcoma family of tumors: Ewing sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. Pizzo P.A., Poplack D.G. Principles and practice of pediatric oncology. 4th edition:2000;973-1016 Lippincot-Williams & Wilkins Publishers, Philadelphia.
2. Sandberg A.A., Bridge J.A. Updates on cytogenetics and molecular genetics of bones and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors. Cancer Genet Cytogenet. 123:2000;1-26.
3. Ladanyi M. EWS-FLI1 and Ewing's sarcoma: recent molecular data and new insights. Cancer Biol Ther. 1:2002;330-336.
4. Dehner L.P. Primitive neuroectodermal tumor and Ewing's sarcoma. Am J Surg Pathol. 17:1993;1-13.
5. Delattre O., Zucman J., Melot T., Garau X.S., Zucker J.U., Lenoir G.M., Ambros P.F., Sheer D., Turc-Carel C., Triche T.J., Aurias A., Thomas G. The Ewing family of tumors: a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med. 331:1994;294-299.
6. Sorensen P.H., Lessnick S.L., Lopez-Terrada D., Liu X.F., Triche T.J., Denny C.T. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet. 6:1994;146-151.
7. Jeon I.S., Davis J.N., Braun B.S., Sublett J.E., Roussel M.F., Denny C.T., Shapiro D.N. A variant Ewing's sarcoma translocation, t(7;22), fuses the EWS gene to the ETS gene ETV1. Oncogene. 10:1995;1229-1234.
8. Urano F., Umezawa A., Hong W., Kikuchi H., Hata J. A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. Biochem Biophys Res Commun. 219:1996;608-612.
9. Peter M., Couturier J., Paquement H., Michon J., Thomas G., Magdelenat H., Delattre D. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene. 14:1997;1159-1164.
10. Maurici D., Perez-Atayde A., Grier H.E., Baldini N., Serra M., Fletcher J.A. Frequency and implication of chromosome 8 and 12 gains in Ewing sarcoma. Cancer Genet Cytogenet. 100:1998;106-110.
11. Armengol G., Tarkkanen M., Virolainen M., Forus A., Valle J., Bohling T., Asko-Seljavaara S., Blomqvist C., Elomaa I., Karaharju E., Kivioja A.H., Siimes M.A., Tukiainen E., Caballin M.R., Myklebost O., Knuutila S. Recurrent gains of 1q, 8 and 12 in the Ewing family of tumors by comparative genomic hybridization. Br J Cancer. 75:1997;1403-1409.
12. Stark B., Mor C., Jeison M., Gobuzov R., Cohen I.J., Goshen Y., Stein J., Fisher S., Ash S., Yaniv I., Zaizov R. Additional chromosome 1q abberations and der(16)t(1;16), correlation to the phenotypic expression and clinical behavior of the Ewing family of tumors. J Neurooncol. 31:1997;3-8.
13. Hattinger C.M., Rumpler S., Strehl S., Ambros I.M., Zoubek A., Potschger U., Gadner H., Ambros P.F. Prognostic impact of deletions at 1p36 and numerical abberations in ES/PNET. Genes Chromosome Cancer. 24:1999;243-254.
14. Modrich P., Lahue R.S. Mismatch repair in replication fidelity, genetic recombination and cancer biology. Annu Rev Biochem. 65:1996;101-133.
15. Leach F.S., Nicolaides N.C., Papadopoulos N., Liu B., Jen J., Parsons R., Peltomaki P., Sistonen P., Aaltonen L.A., Nystrom-Lahti M., Guan X.-Y., Zhang J., Meltzer P., Yu J.-W., Kao F.-T., Chen D.J., Cerosaletti K.M., Fournier R.E.K., Todd S., Lewis T., Leach R.J., Naylor S.L., Weissenbach J., Mecklin J.-P., Järvinen H., Petersen G.M., Hamilton S.R., Green J., Jass J., Watson P., Lynch H.T., Trent J.M., de la Chapelle A., Kinzler K.W., Vogelstein B. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell. 75:1993;1215-1225.
16. Fishel R., Lescoe M.K., Rao M.R., Copeland N.G., Jenkins N.A., Garber J., Kane M., Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 75:1993;1027-1038.
17. Modrich P. Mismatch repair, genetic stability and cancer. Science. 266:1994;1959-1960.
18. Ionov Y., Peinado M.A., Malkhosyan S., Shibata D., Perucho M. Ubiquitous somatic mutations in simple repeated sequences revealed a new mechanism for colonic carcinogenesis. Nature. 363:1993;558-561.
19. Thibodeau S.N., Bren G., Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 260:1993;816-819.
20. Eshleman J.R., Markowitz S.D. Mismatch repair defects in human carcinogenesis. Hum Mol Genet. 5:1996;1489-1494.
21. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instabilities in human cancers. Nature. 396:1998;643-649.
22. Vogelstein B. Allelotype of colorectal carcinomas. Science. 244:1989;207-211.
23. Boige V., Laurent-Puig P., Fouchet P., Flejou J.F., Monges G., Bedossa P., Bioulac-Sage P., Cpron F., Schmitz A., Olschwang S., Thomas G. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res. 57:1997;1986-1990.
24. Seymour A.B. Allelotype of pancreatic adenocarcinoma. Cancer Res. 54:1994;2761-2764.
25. Radford D.M. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p, and 17q. Cancer Res. 55:1995;3399-3405.
26. Miller S.A., Dykes D.D., Poleski H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 3:1988;1215.
27. Yamamoto H., Itoh F., Nakamura H., Fukushima H., Sasaki S., Perucho M., Imai K. Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability. Cancer Res. 61:2001;3139-3144.
28. Choi S.W., Lee K.J., Bae Y.A., Min K.O., Kwon M.S., Kim K.M., Rhyu M.G. Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival. Clin Cancer Res. 8:2002;2311-2322.
29. Muresu R., Sini M.C., Cossu A., Tore S., Baldinu P., Manca A., Pisano M., Loddo C., Dessole S., Pintus A., Tanda F., Palmieri G. Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer. Eur J Cancer. 38:2002;1802-1809.
30. Miyoshi E., Haruma K., Hiyama T., Tanaka S., Yoshihara M., Shimamoto F., Chayama K. Microsatellite instability is a genetic marker for the development of multiple gastric cancers. Int J Cancer. 95:2001;350-353.
31. Gafanovich A., Ramu N., Krichevsky S., Pe'er J., Amir G., Ben-Yehuda D. Microsatellite instability and p53 mutations in pediatric secondary malignant neoplasms. Cancer. 85:1999;504-510.
32. Tarkkanen M., Aaltonen L.A., Bohling T., Kivioja A., Karaharju E., Elomaa I., Knuutila S. No evidence of microsatellite instability in bone tumors. Br J Cancer. 74:1996;453-455.
33. Suwa K., Ohmori M., Miki H. Microsatellite alterations in various sarcomas in Japanese patients. J Orthop Sci. 4:1999;223-230.
34. Zielenska M., Zhang Z.M., Ng K., Marrano P., Bayani J., Ramirez O.C., Sorensen P., Thorner P., Greenberg M., Squire J.A. Acquisition of secondary structural chromosomal changes in pediatric Ewing sarcoma is a probable prognostic factor for tumor response and clinical outcome. Cancer. 91:2001;2156-2164.
35. Amiel A., Ohali A., Fejgin M., Sardos-Albertini F., Bouaron N., Cohen I.J., Yaniv I., Zaizov R., Avigad S. Molecular cytogenetic parameters in Ewing sarcoma. Cancer Genet Cytogenet. 140:2003;107-112.
36. Alonso M., Hamelin R., Kim M., Porwancher K., Sung T., Parhar P., Miller D.C., Newcomb E.W. Microsatellite instability occurs in distinct subtypes of pediatric but not adult central nervous system tumors. Cancer Res. 61:2001;2124-2128.
37. Mayer F., Gillis A.J.M., Dinjens W., Oosterhuis J.W., Bokemeyer C., Looijenga L.H.J. Microsatellite instability of germ cell tumors is associated with resistance to systemic treatment. Cancer Res. 62:2002;2758-2760.
38. Ribic C.M., Sargent D.J., Moore M.J., Thibodeau S.N., French A.J., Goldberg R.M., Hamilton S.R., Laurent-Puig P., Gryfe R., Shepherd L.E., Tu D., Redston M., Gallinger S. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 349:2003;247-257.
39. Fong C.T., Dracopoli N.C., White P.S., Merril P.T., Griffith R.C., Housman D.E., Brodeur G.M. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci USA. 86:1989;3753-3757.
40. Brodeur G.M., Nakagawara A. Molecular basis of clinical heterogeneity in neuroblastoma. Am J Pediatr Hematol Oncol. 14:1992;111-116.
41. Mathew S., Murty V.V., Bosl G.J., Chaganti R.S. Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome in human male germ cell tumors. Cancer Res. 54:1994;6265-6269.
42. Hu J., Schuster A.E., Fritsch M.K., Schneider D.T., Lauer S., Perlman E.J. Deletion mapping of 6q21-26 and frequency of 1p36 deletion in childhood endodermal sinus tumors by microsatellite analysis. Oncogene. 20:2001;8042-8044.
43. Schwab M., Prami C., Amler L.C. Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer. 16:1996;211-219.
44. Steinberg R., Freud E., Zer M., Ziperman I., Goshen Y., Ash S., Stein J., Zaizov R., Avigad S. High frequency of loss of heterozygosity for 1p35-p36 (D1S247) in Wilms tumor. Cancer Genet Cytogenet. 117:2000;136-139.
45. Grundy P.E., Telzerow P.E., Breslow N., Moksness J., Huff V., Paterson M.C. Loss of heterozygosity for chromosomes 16q and 1p in Wilms tumors predicts an adverse outcome. Cancer Res. 54:1994;2331-2333.
46. Yin X.L., Pang J.C., Liu Y.H., Chong E.Y., Cheng M.F.Y., Poon W., Ng H. Analysis of loss of heterozygosity on chromosomes 10q, 11, and 16 in medulloblastomas. J Neurosurg. 94:2001;799-805.
47. Abraham S., Wu T.T., Hruban R.H., Lee J.H., Yeo C.J., Conlon K., Brennan M., Cameron J.L., Klimstra S. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma. Am J Pathol. 160:2002;953-962.
48. El-Naggar A.K., Hurr K., Huff V., Luna M.A., Goepfert H., Batsakis J.G. Allelic loss and replication errors at microsatellite loci on chromosome 11p in head and neck squamous carcinoma: association with aggressive biological features. Clin Cancer Res. 2:1996;903-907.
49. Bepler G., Garcia-Blanco M.A. Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer. Proc Natl Acad Sci USA. 91:1994;5513-5517.
50. Shaw M.E., Knowles M.A. Deletion mapping of chromosome 11 in carcinoma of the bladder. Genes Chromosomes Cancer. 13:1995;1-8.
51. Jen J., Kim H., Piantadosi S., Liu Z.F., Levitt R.C., Sistonen P., Kinzler K.W., Vogelstein B., Hamilton S.R. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med. 331:1994;213-221.
52. Shiseki M., Kohno T., Adachi J., Okazaki T., Otsuka T., Mizoguchi H., Noguchi M., Hirohashi S., Yokota J. Comparative allelotype of early stage non-small cell lung carcinomas. Genes Chromosomes Cancer. 17:1996;71-77.
53. Jones J.W., Raval J.R., Beals T.F., Worsham M.J., Van Dyke D.L., Esclamado R.M., Wolf G.T., Bradford C.R., Miller T., Carey T.E. Frequent loss of heterozygosity on chromosome arm 18q in squamous cell carcinomas. Arch Otolaryngol Head Neck Surg. 123:1997;610-614.
54. Hahn S.A., Hoque A.T., Moskaluk C.A., da Costa L.T., Schutte M., Rozenblum E., Seymour A.B., Weinstein C.L., Yeo C.J., Hruban R.H., Kem S.E. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res. 56:1996;490-494.
55. Ueda T., Komiya A., Emi M., Suzuki H., Shiraishi T., Yatani R., Masai M., Yasuda K., Ito H. Allelic losses on 18q21 are associated with progression and metastasis in human prostate cancer. Genes Chromosomes Cancer. 20:1997;140-147.
56. Graziano F., Cascinu S., Staccioli M.P., Catalano V., Rossi M.C., Baldelli A.M., Giordani P., Muretto P., Catalano G. Potential role and chronology of abnormal expression of the deleted in colon cancer (DCC) and the p53 proteins in the development of gastric cancer. BMC Cancer. 1:2001;9. (available at http://www.biomedcentral.com/1471-2407/1/9.).
57. Takita J., Hayashi Y., Takei K., Yamaguchi N., Hanada R., Yamamoto K., Yokota J. Allelic imbalance on chromosome 18 in neuroblastoma. Eur J Cancer. 36:2000;508-513.
58. Kovar H., Auinger A., Jug G., Aryee D., Zoubek A., Salzer-Kuntschik M., Gadner H. Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumors. Oncogene. 8:1993;2683-2690.
59. de Alava E., Antonescu C.R., Panizo A., Leung D., Meyers P.A., Huvos A.G., Pardo- Mindan, Healey J.H., Ladanyi M. Prognostic impact of p53 status in Ewing sarcoma. Cancer. 89:2000;783-792.